US Stem Cell Inc (USRM)

[Dragon Lady]

This must be the "big conference call effect, no???? LOL. All less than 10 or so minutes of it, according to statements I read here of those who listened to it (a grand total of about 7 1/2 minutes by one account posted here)

Bid buried at only .0071 on open? Ask is at .008 w/ BMAK sitting hard on it with the usual 10K share block? After the "big call" and all? Wow.

0.0071 / 0.008 (18000 x 54600)

http://www.otcmarkets.com/stock/BHRT/quote


I thought it was predicted to be 100% certain "going big" based on this incredible "conference call" thingy alone this time? Like all the 7 yrs of "going big" predictions since it traded public in 2008 and went straight down from $5.25 a share to now about .008 a share, a loss to the common shares of about 99.99% of their value. An impressive run to say the least IMO.

What happened I wonder? The 10 minutes or 7 1/2 minutes of the "big call" weren't didn't light the fire to launch this baby just yet (AGAIN)?? I guess not sure what I am missing here?

Is it possible the dilution, the 65 MILLION shares just in Jan, Feb and early March of 2015 could be having an effect or something like that, just maybe?

From the latest filed 10-K, PAGE F-34:

Subsequent stock issuances

In January 2015, the Company issued 4,783,568 shares of its common stock in settlement for services, provided 14,299,567 shares of its common stock in settlement of $49,500 of outstanding convertible notes payable, and $2,981 accrued interest and 2,096,450 shares of its common stock for net proceeds of $16,118 from equity drawdown under the Magna Purchase Agreement.

In February 2015, the Company sold an aggregate of 1,443,656 shares of its common stock for net proceeds of $16,270. In connection with the stock sale, the Company issued an aggregate of 1,443,656 warrants to purchase the Company’s common stock for five years at $0.01127 per share. In addition, the Company issued 20,219,367 shares of its common stock in settlement of $132,500 of outstanding convertible notes payable and $2,520 accrued interest and 16,556,976 shares of its common stock for net proceeds of $135,645 from equity drawdown under the Magna Purchase Agreement.

In March 2015, the Company issued 6,185,432 shares of its common stock in settlement of $25,000 of outstanding convertible notes payable and $1,226 accrued interest. In addition, the Company issued 635,357 shares of its common stock as true up shares relating to the February 2015 equity drawdown under the Magna Purchase Agreement.

And same page:

"Subsequent financing

On January 7, 2015, the Company entered into a Securities Purchase Agreement with KBM Worldwide, Inc. (“KBM”), for the sale of an 8% convertible note in the principal amount of $38,000 (the “Note”).

The Note bears interest at the rate of 8% per annum. All interest and principal must be repaid on October 9, 2015. The Note is convertible into common stock, at KBM’s option, at a 45% discount to the average of the three lowest closing bid prices of the common stock during the 10 trading day period prior to conversion. In the event the Company prepays the Note in full, the Company is required to pay off all principal, interest and any other amounts owing multiplied by (i) 140% if prepaid during the period commencing on the closing date through 179 days thereafter. After the expiration of 180 days following the date of the Note, the Company has no right of prepayment.

On January 28, 2015, the Company entered into a Securities Purchase Agreement with Fourth Man, LLC., for the sale of an 9.5% convertible note in the principal amount of $25,000 (the “Note”).

The Note bears interest at the rate of 9.5% per annum. All interest and principal must be repaid on January 27, 2016. The Note is convertible into common stock, at Asher’s option, at a 47% discount to the lowest daily closing trading price of the common stock during the 10 trading day period prior to conversion. In the event the Company prepays the Note in full, the Company is required to pay off all principal at 150%, interest and any other amounts.

On February 19, 2015, the Company entered into a Securities Purchase Agreement with Vis Vires Group, Inc. (“VIS”), for the sale of an 8% convertible note in the principal amount of $38,000 (the “Note”).

The Note bears interest at the rate of 8% per annum. All interest and principal must be repaid on November 23, 2015. The Note is convertible into common stock, at VIS’s option, at a 45% discount to the average of the three lowest closing bid prices of the common stock during the 10 trading day period prior to conversion. In the event the Company prepays the Note in full, the Company is required to pay off all principal, interest and any other amounts owing multiplied by (i) 140% if prepaid during the period commencing on the closing date through 179 days thereafter. After the expiration of 180 days following the date of the Note, the Company has no right of prepayment.
"

I mean, could any of those 10-K based FACTS have maybe a tad-bit of anything to do with what the share price is doing? Maybe, possibly? I mean, I thought this "revenues thingy" has/had pretty much "fixed" everything according to all these statements and "reports" and great PR and what not, so why did all that "stuff" on page F-34 of the most recent filed 10-K occur then? Why? Makes no sense to me personally? Add up those "subsequent shares issued" in just early 2015- it adds up to over 65 MILLION shares of pure dilution and at very low share prices? Why would they do that? And, why would they be borrowing in shares-for-cash deals amounts like $25K and $38K and issuing shares for $16K at a time and all? Didn't the "revenues thingy" fix all that?

Not sure I "get it", how this is all working out and about to "go big" here I guess? Just wondering out loud is all?